Skip to main content

Media Relations

Our Press and Media Relations team offers the latest press releases, background information on various topics, and image material for download.

Innovative diagnostic solutions for acute and critical care conditions

We are committed to improving patient outcomes with innovative diagnostic solutions for acute and critical care that allow the diagnosis, outcome prediction, and monitoring of patients with acute medical conditions.

SphingoTec is a privately held company located in Hennigsdorf near Berlin, Germany. With a long history of biomarker discovery, development, and validation, we develop and market innovative IVD solutions for our novel and proprietary blood-based protein biomarkers. 
Our aspiration is to effectively translate scientific advancements into routine clinical practice. We develop biomarkers addressing diagnostically underserved acute and critical care conditions such as sepsis, acute heart failure, and acute kidney injury, which are some of the biggest mortality drivers worldwide.

Subscribe to our Newsletter

Follow the link below to subscribe to our Newsletter & receive updates on our company and products

Subscribe now

Contact our Press & Media Relations Team

Ruxandra Lenz

Head of Marketing & Communications


Latest News

09. May 2023
SphingoTec has been successfully re-certified according to ISO 13485 and received its first IVDR certificate for its IVD product sphingotest® penKid®.
Read more
04. April 2023
The Acute Disease Quality Initiative (ADQI) has published a consensus statement that strongly recommends using innovative biomarkers to improve the management of sepsis-associated acute kidney injury (SA-AKI).
Read more
23. February 2023
Diagnostic company SphingoTec is pleased to announce the appointment of Dr. Florian Uhle as the company's new Medical Director. Dr. Uhle is a subject matter expert in translating innovations into routine clinical practice with a broad experience in both clinical and corporate settings.
Read more

Media Coverage

15. November 2022
Boditech Med will develop and make point-of-care tests for acute kidney injury using a kidney function biomarker licensed from SphingoTec.
Read more
23. September 2022
Acute kidney injury (AKI) is a life-threatening disease that has no obvious symptoms in the early stages. Early identification of patients with AKI is one of the most critical unmet needs of physicians in their daily clinical practice. The focus of this article is on functional kidney biomarkers since it is not possible for damage markers to estimate the glomerular filtration rate (GFR).
Read more
18. August 2022
International medical leaders discussed the latest developments in diagnostic and therapeutic innovations for advancing precision medicine in critically ill patients.
Read more

Watch our upcoming and latest Webinars on demand

Find out about the latest breakthroughs in clinical diagnostics and get valuable insights from international healthcare experts. To help improve patient management in acute and critical care conditions, we have created a series of webinars that look at the latest diagnostic innovations and how they influence today's clinical practice. Click here to see all available Webinars.


Using bio-ADM and penKid for optimization of AHF management in daily clinical practice

Speaker: Prof. John Parissis MD, PhD,  Attikon General Hospital


Using Proenkephalin as a Novel Biomarker to Estimate GFR

Speaker: Prof. Dr. Peter Pickkers, Radboud University, Nijmegen


Point-of-care Diagnostics in the Emergency Department: Better Patient Management

Speaker: Prof. Salvatore Di Somma, MD PhD; University La Sapienza Rome

Press photos for download